Q3 2025 Earnings Call October 29, 2025 4:30 PM EDTCompany ParticipantsChristopher Lewis - Vice President of Investor ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.

A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely ...

Overview of Epigenetics MarketThe global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a value of USD 9.11 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...

Get the latest on CMS Energy's Q3 2025 earnings: robust growth, $25B investment pipeline, and raised guidance.

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in metastatic pancreatic cancer. Tumor-treating fields (TTFields) improve overall ...

Explore Generect’s real-time data pipeline. Learn how 400M contacts power instant lead discovery and seamless outreach campaigns.

Tensions at Manhattan's immigration courts are reaching a boiling point. Last week, Immigration and Customs Enforcement reinstated the officer who was initially relieved of duties after shoving an ...

The atypical teratoid/rhabdoid tumor market growth is driven by rising molecular diagnosis and increased awareness of this ...